Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Genotoxic Effects of Tributyltin and Triphenyltin Isothiocyanates, Cognate RXR Ligands: Comparison in Human Breast Carcinoma MCF 7 and MDA-MB-231 Cells

L. Hunakova, E. Horvathova, K. Majerova, P. Bobal, J. Otevrel, J. Brtko,

. 2019 ; 20 (5) : . [pub] 20190309

Jazyk angličtina Země Švýcarsko

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027728

Grantová podpora
APVV-15-0372 Agentúra na Podporu Výskumu a Vývoja
2/0084/16, 2/0092/16 and 1/0136/18 Scientific Grant Agency of the Ministry of Education of Slovak Republic and the Academy of Sciences
320/2018/FaF IGA UVPS Brno
TRANSMED, ITMS: 26240120008 and ITMS: 26240220071 and TRANSMED 2, ITMS: 26240120030 Research & Development Operational Programme funded by the ERDF

The cytotoxicity of two recently synthesized triorganotin isothiocyanate derivatives, nuclear retinoid X receptor ligands, was tested and compared in estrogen-receptor-positive MCF 7 and -negative MDA-MB-231 human breast carcinoma cell lines. A 48 h MTT assay indicated that tributyltin isothiocyanate (TBT-ITC) is more cytotoxic than triphenyltin isothiocyanate (TPT-ITC) in MCF 7 cells, and the same trend was observed in the MDA-MB-231 cell line. A comet assay revealed the presence of both crosslinks and increasing DNA damage levels after the 17 h treatment with both derivatives. Differences in cytotoxicity of TBT-ITC and TPT-ITC detected by FDA staining correspond to the MTT data, communicating more pronounced effects in MCF 7 than in the MDA-MB-231 cell line. Both derivatives were found to cause apoptosis, as shown by the mitochondrial membrane potential (MMP) depolarization and caspase-3/7 activation. The onset of caspase activation correlated with MMP dissipation and the total cytotoxicity more than with the amount of active caspases. In conclusion, our data suggest that the DNA damage induced by TBT-ITC and TPT-ITC treatment could underlie their cytotoxicity in the cell lines studied.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027728
003      
CZ-PrNML
005      
20190815114630.0
007      
ta
008      
190813s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms20051198 $2 doi
035    __
$a (PubMed)30857277
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hunakova, Luba $u Cancer Research Institute, BMC, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovak Republic. Luba.Hunakova@savba.sk.
245    10
$a Genotoxic Effects of Tributyltin and Triphenyltin Isothiocyanates, Cognate RXR Ligands: Comparison in Human Breast Carcinoma MCF 7 and MDA-MB-231 Cells / $c L. Hunakova, E. Horvathova, K. Majerova, P. Bobal, J. Otevrel, J. Brtko,
520    9_
$a The cytotoxicity of two recently synthesized triorganotin isothiocyanate derivatives, nuclear retinoid X receptor ligands, was tested and compared in estrogen-receptor-positive MCF 7 and -negative MDA-MB-231 human breast carcinoma cell lines. A 48 h MTT assay indicated that tributyltin isothiocyanate (TBT-ITC) is more cytotoxic than triphenyltin isothiocyanate (TPT-ITC) in MCF 7 cells, and the same trend was observed in the MDA-MB-231 cell line. A comet assay revealed the presence of both crosslinks and increasing DNA damage levels after the 17 h treatment with both derivatives. Differences in cytotoxicity of TBT-ITC and TPT-ITC detected by FDA staining correspond to the MTT data, communicating more pronounced effects in MCF 7 than in the MDA-MB-231 cell line. Both derivatives were found to cause apoptosis, as shown by the mitochondrial membrane potential (MMP) depolarization and caspase-3/7 activation. The onset of caspase activation correlated with MMP dissipation and the total cytotoxicity more than with the amount of active caspases. In conclusion, our data suggest that the DNA damage induced by TBT-ITC and TPT-ITC treatment could underlie their cytotoxicity in the cell lines studied.
650    _2
$a protinádorové látky $x chemie $x farmakologie $7 D000970
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a nádory prsu $x farmakoterapie $x genetika $x metabolismus $7 D001943
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a poškození DNA $x účinky léků $7 D004249
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a isothiokyanatany $x chemie $x farmakologie $7 D017879
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a membránový potenciál mitochondrií $x účinky léků $7 D053078
650    _2
$a organocínové sloučeniny $x chemie $x farmakologie $7 D009947
650    _2
$a retinoidní X receptory $x metabolismus $7 D047488
650    _2
$a trialkylcínové sloučeniny $x chemie $x farmakologie $7 D014220
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Horvathova, Eva $u Cancer Research Institute, BMC, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovak Republic. Eva.Horvathova@savba.sk.
700    1_
$a Majerova, Karolina $u Cancer Research Institute, BMC, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovak Republic. Karolina.Majerova@savba.sk.
700    1_
$a Bobal, Pavel $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackeho 1946/1, 612 42 Brno, Czech Republic. bobalp@vfu.cz.
700    1_
$a Otevrel, Jan $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackeho 1946/1, 612 42 Brno, Czech Republic. otevrelj@vfu.cz.
700    1_
$a Brtko, Julius $u Institute of Experimental Endocrinology, BMC, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovak Republic. Julius.Brtko@savba.sk.
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 5 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30857277 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190815114858 $b ABA008
999    __
$a ok $b bmc $g 1432877 $s 1066188
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 20 $c 5 $e 20190309 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a APVV-15-0372 $p Agentúra na Podporu Výskumu a Vývoja
GRA    __
$a 2/0084/16, 2/0092/16 and 1/0136/18 $p Scientific Grant Agency of the Ministry of Education of Slovak Republic and the Academy of Sciences
GRA    __
$a 320/2018/FaF $p IGA UVPS Brno
GRA    __
$a TRANSMED, ITMS: 26240120008 and ITMS: 26240220071 and TRANSMED 2, ITMS: 26240120030 $p Research & Development Operational Programme funded by the ERDF
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...